Given that both TET1 and TET2 are severely reduced in osteoporosis, pharmacological re-induction of TET1/TET2 may be of therapeutic benefit to individuals suffering from age-related bone loss or osteoporosis [58]. Here, TET2 is linked to osteoporosis.